CGEN Stock CGEN is expected to report earnings to fall -200% to -11 cents per share on May 09

A.I.dvisor
at Tickeron.com
05/08/24
Loading...
CGEN - Compugen Ltd
Compugen Ltd Earnings Graph
Q1'24
Est.
$-0.11
Q4'23
Beat
by $0.01
Q3'23
Missed
by $0.01
Q2'23
Beat
by $0.01
Q1'23
Beat
by $0.01
The last earnings report on December 31 showed earnings per share of 11 cents, beating the estimate of 10 cents. P/B Ratio (3.011) is normal, around the industry mean (10.346). P/E Ratio (0.000) is within average values for comparable stocks, (113.451). CGEN's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.447). CGEN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). P/S Ratio (5.774) is also within normal values, averaging (231.135). With 301.50K shares outstanding, the current market capitalization sits at 189.81M.
View a ticker or compare two or three
CGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a maker of drug and diagnostics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
68
Web
https://www.cgen.com